KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Long-Term Debt Repayments: 2012-2025

Historic Long-Term Debt Repayments for Pacira BioSciences (PCRX) over the last 1 years, with Sep 2025 value amounting to $202.5 million.

  • Pacira BioSciences' Long-Term Debt Repayments was N/A to $202.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $572.2 million, marking a year-over-year change of. This contributed to the annual value of $191.0 million for FY2024, which is N/A change from last year.
  • Per Pacira BioSciences' latest filing, its Long-Term Debt Repayments stood at $202.5 million for Q3 2025, which was up 5.13% from $192.6 million recorded in Q1 2022.
  • Pacira BioSciences' Long-Term Debt Repayments' 5-year high stood at $202.5 million during Q3 2025, with a 5-year trough of $192.6 million in Q1 2022.
  • For the 1-year period, Pacira BioSciences' Long-Term Debt Repayments averaged around $202.5 million, with its median value being $202.5 million (2025).